267 related articles for article (PubMed ID: 19233152)
1. Hyperhomocysteinemia, paraoxonase concentration and cardiovascular complications in Tunisian patients with nondiabetic renal disease.
Kerkeni M; Letaief A; Achour A; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2009 Jun; 42(9):777-82. PubMed ID: 19233152
[TBL] [Abstract][Full Text] [Related]
2. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease.
Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K
Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684
[TBL] [Abstract][Full Text] [Related]
3. [Characteristics of hyperhomocysteinemia in dialysis patients].
Lovcić V; Kes P; Reiner Z
Acta Med Croatica; 2006; 60(1):21-6. PubMed ID: 16802568
[TBL] [Abstract][Full Text] [Related]
4. Plasma homocysteine levels and cardiovascular mortality in patients with end-stage renal disease.
Buccianti G; Baragetti I; Bamonti F; Furiani S; Dorighet V; Patrosso C
J Nephrol; 2004; 17(3):405-10. PubMed ID: 15365961
[TBL] [Abstract][Full Text] [Related]
5. Homocysteine increases the risk associated with hyperlipidaemia.
Daly C; Fitzgerald AP; O'Callaghan P; Collins P; Cooney MT; Graham IM;
Eur J Cardiovasc Prev Rehabil; 2009 Apr; 16(2):150-5. PubMed ID: 19276985
[TBL] [Abstract][Full Text] [Related]
6. Serum paraoxonase phenotype distribution in exudative age-related macular degeneration and its relationship to homocysteine and oxidized low-density lipoprotein.
Javadzadeh A; Ghorbanihaghjo A; Bahreini E; Rashtchizadeh N; Argani H; Alizadeh S
Retina; 2012 Apr; 32(4):658-66. PubMed ID: 22030834
[TBL] [Abstract][Full Text] [Related]
7. Hyperhomocysteinemia as a cardiovascular risk factor in Indian women: determinants and directionality.
Pandey SN; Vaidya AD; Vaidya RA; Talwalkar S
J Assoc Physicians India; 2006 Oct; 54():769-74. PubMed ID: 17214272
[TBL] [Abstract][Full Text] [Related]
8. [Increase of homocysteine in cardiovascular diseases in Hungary].
Balogh E; Czuriga I; Bereczky Z; Boda K; Koszegi Z; Kónya C; Császár A; Muszbek L; Edes I; Ferdinandy P
Orv Hetil; 2006 Sep; 147(35):1685-90. PubMed ID: 17051744
[TBL] [Abstract][Full Text] [Related]
9. Effect of oxidative stress on antioxidant enzyme activities, homocysteine and lipoproteins in chronic kidney disease.
Atamer A; Kocyigit Y; Ecder SA; Selek S; Ilhan N; Ecder T; Atamer Y
J Nephrol; 2008; 21(6):924-30. PubMed ID: 19034878
[TBL] [Abstract][Full Text] [Related]
10. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome.
Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M
Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283
[TBL] [Abstract][Full Text] [Related]
11. Hyperhomocysteinemia in inflammatory bowel disease patients without past intestinal resections: correlations with cobalamin, pyridoxine, folate concentrations, acute phase reactants, disease activity, and prior thromboembolic complications.
Erzin Y; Uzun H; Celik AF; Aydin S; Dirican A; Uzunismail H
J Clin Gastroenterol; 2008; 42(5):481-6. PubMed ID: 18344891
[TBL] [Abstract][Full Text] [Related]
12. Relationship of homocysteine with other risk factors and outcome of ischemic stroke.
Kalita J; Kumar G; Bansal V; Misra UK
Clin Neurol Neurosurg; 2009 May; 111(4):364-7. PubMed ID: 19185985
[TBL] [Abstract][Full Text] [Related]
13. [Paraoxonase 1 (PON1) activity and lipid parameters in Tunisian smokers].
Haj Mouhamed D; Ezzaher A; Araoud M; Neffati F; Douki W; Najjar MF
Ann Biol Clin (Paris); 2010; 68(2):143-7. PubMed ID: 20348046
[TBL] [Abstract][Full Text] [Related]
14. Factors involved in baseline hyperhomocysteinemia in renal transplantation.
Díaz JM; Sainz Z; Gich I; Guirado LL; Puig T; Oliver A; Montañés R; Chuy E; Solà R
Transplant Proc; 2005 Nov; 37(9):3799-801. PubMed ID: 16386543
[TBL] [Abstract][Full Text] [Related]
15. Effects of plasma homocysteine levels on serum HTase/PON activity in patients with type 2 diabetes.
Weijun G; Juming L; Guoqing Y; Jingtao D; Qinghua G; Yiming M; Changyu P
Adv Ther; 2008 Sep; 25(9):884-93. PubMed ID: 18781288
[TBL] [Abstract][Full Text] [Related]
16. Decreased paraoxonase 1 (PON1) lactonase activity in hemodialyzed and renal transplanted patients. A novel cardiovascular biomarker in end-stage renal disease.
Sztanek F; Seres I; Harangi M; Lőcsey L; Padra J; Paragh GJ; Asztalos L; Paragh G
Nephrol Dial Transplant; 2012 Jul; 27(7):2866-72. PubMed ID: 22247228
[TBL] [Abstract][Full Text] [Related]
17. The relation between plasma homocysteine level and cardiovascular risk factors in cerebral ischemia.
Huang CW; Chen TH; Lin HS; Tseng YL; Lai SL; Chen WH; Chen SS; Liu JS
Acta Neurol Taiwan; 2007 Jun; 16(2):81-5. PubMed ID: 17685131
[TBL] [Abstract][Full Text] [Related]
18. [Homocysteinemia and coronary artery disease: a case-control study in a Tunisian population].
Souissi M; Feki M; Mourali S; Enneifer M; Omar S; Sanhaji H; Mechmeche R; Mebazaa A; Kaabachi N
Arch Mal Coeur Vaiss; 2006 Sep; 99(9):781-5. PubMed ID: 17067095
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine, lipid indices and antioxidants in patients with ischaemic heart disease from Maharashtra, India.
Bhagwat VR; Yadav AS; Rathod IM
Singapore Med J; 2009 Apr; 50(4):418-24. PubMed ID: 19421689
[TBL] [Abstract][Full Text] [Related]
20. Hyperhomocysteinemia is associated with deep venous thrombosis of the lower extremities in Tunisian patients.
Omar S; Ghorbel IB; Feki H; Souissi M; Feki M; Houman H; Kaabachi N
Clin Biochem; 2007 Jan; 40(1-2):41-5. PubMed ID: 17020757
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
